These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 18834847)

  • 1. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
    Tendler M; Simpson AJ
    Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
    Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
    Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica.
    Zafra R; Buffoni L; Martínez-Moreno A; Pérez-Ecija A; Martinez-Moreno FJ; Pérez J
    J Comp Pathol; 2008 Nov; 139(4):169-76. PubMed ID: 18768187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
    Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
    Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
    Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
    Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in vaccine research against schistosomiasis in Brazil.
    Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC
    Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of defined antigen vaccines against Schistosoma bovis and S. japonicum in bovines.
    Bashir M; Bickle Q; Bushara H; Cook L; Shi F; He D; Huggins M; Lin J; Malik K; Moloney A
    Trop Geogr Med; 1994; 46(4 Spec No):255-8. PubMed ID: 7825230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
    Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
    Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
    Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress on vaccines against parasites.
    Engers HD; Bergquist R; Modabber F
    Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving animal and human health through understanding liver fluke immunology.
    Piedrafita D; Spithill TW; Smith RE; Raadsma HW
    Parasite Immunol; 2010 Aug; 32(8):572-81. PubMed ID: 20626812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells.
    Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
    Mendes RE; Zafra R; Pérez-Ecija RA; Buffoni L; Martínez-Moreno A; Tendler M; Pérez J
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):698-705. PubMed ID: 20835620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.